. . . . which will long term cost the NHS less money as there won’t be as many complications.
i had a phone call off my gp practise yesterday to say i could have the sensor theres me buzzing half an hour later another phone call to say they had made a mistake and couldnt prescribe it as pan mersey havent approved it {think thats what they called it as i was too busy giving them a piece of my mind :***:}any way had consultant meeting this morning ranting on to her and she said she couldnt prescribe it either its an absolute joke as i pointed out the amount of strips i use would defo out weigh the cost of sensor i go through 150 strips every 2 weeks or so but all to no avail she did say she will try and get me a spare one but i wont hold my breathOkay guys - that is an awful petition. Technically, the Libre is now available free on the NHS - the government can point at the NHS BSA Drug Tariff and say "Look, there it is."
The issue is that local CCGs (that the Government has no control or influence over) are refusing to pay for it as there is not enough "real evidence" as in, "the type of evidence that proves beyond refute that Libre benefits people at an appropriate cost".
Your best bet is NOT to sign a faceless petition on a website. It is to speak to your local MP and get them involved locally.
Okay guys - that is an awful petition. Technically, the Libre is now available free on the NHS - the government can point at the NHS BSA Drug Tariff and say "Look, there it is."
I also think that the suggestion that it will save the NHS money long term must apply to type IIs as much as type Is. The figures available on the diabetes.co.uk website support that. In some ways the just having a petition for type Is could be somewhat divisive. I'm hoping that those who will really benefit will get approval from their CCG. If you are able to check out the Libre Facebook pages there are already several anecdotal messages of success in different areas..
If you are able to check out the Libre Facebook pages there are already several anecdotal messages of success in different areas..
That's not the issue with funding. Accuracy isn't something that's even been raised. The issue is that in the general T1 population, there is no high quality evidence that the Libre improves clinical outcomes.and although a lot of type 1 and 2 will swear by the Libre's success in improving control, there are strips out there that at the moment are cheaper and, by the data collected so far, more accurate......
Accuracy isn't something that's even been raised.
Grampian seems to be actively inviting anecdotal evidence.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?